Pre‐operative spine tumour embolization: Clinical outcomes and effect of embolization completeness

Abstract

AbstractIntroductionTo assess the association between the impact of the completeness of pre‐operative spine tumour embolisation and clinical outcomes, including estimated blood loss (EBL), neurological status and complications.MethodsRetrospective chart review of all preoperative spine tumour embolisation procedures performed over 11 years by a single operator (2007–2018) at Vancouver General Hospital on 44 consecutive patients (mean age 57; 77% males) with 46 embolisation procedures, of which surgery was done en bloc in 26 cases and intralesional in the remaining 20. A multivariable negative binomial regression model was fit to examine the association between EBL and surgery type, tumour characteristics, embolisation completeness and operative duration.ResultsAmong intralesional surgeries, complete versus incomplete embolisation was associated with reduced blood loss (772 vs 1428 mL, P < 0.01). There was no statistically significant difference in neurological outcomes or complications between groups. Highly vascular tumours correlated with greater blood loss than their less vascular counterparts, but tumour location did not have a statistically significant effect.ConclusionThis study provides evidence in support of our hypothesis that complete as opposed to incomplete tumour embolisation correlates with reduced blood loss in intralesional surgeries. Randomised control trials with larger samples are necessary to confirm this benefit and to ascertain other potential clinical benefits.